... of methylphenidate and atomoxetine in treatment ofattentiondeficithyperactivitydisorder in children and adolescents: a meta-analysisRaveen Hanwella, Madhri Senanayake and Varuni de Silva*AbstractBackground: ... Psychiatry 2005, 57:1215-1220.2. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW: The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention- Deficit/ Hyperactivity ... effective thanatomoxetine and may be considered as first line treatmentintreatmentof ADHD in children and adolescents.BackgroundPathophysiology of ADHD is multifactorial and its cau-sal mechanisms...
... Burridge J, AristidesM: Atomoxetine versus methylphenidate as atreatment forADHD in children and adolescents: A meta-analysis of safetydata incorporating active comparator and placebo control-led ... ina placebo-con-trolled relapse prevention trial of atomoxetine responders[48]. In the absence of comparative data, an assumption of parity was made between relapse rates for all activeTable ... evaluation employed a cost-utility analysis tocalculate the incremental cost per quality-adjusted life-year (QALY) gained by atomoxetine compared with the treatment options available in Spain.The...
... Randwick; Prince of Wales Hospital, Randwick, NSW, Australia DIAGNOSIS AND CLASSIFICATION OF ADHD IN CHILDHOOD 33Loney J, Milich R (1982) Hyperactivity, inattention and aggression in clinical practice. ... commentary on the clinical phenomenology, genetics and both pharmacological and non-pharmacological treatmentof adult ADHD. Across the lifespan ADHD impacts on many professionals including general ... print may not be available in electronic books.Anniversary Logo Design: Richard J. Pacifi coLibrary of Congress Cataloging -in- Publication DataHandbook ofattention defi cit hyperactivity disorder...
... at baseline, andwhich between aggressive and non-aggressive patients atbaseline are displayed in Table 2.Among the 50 ADHD patients at the initial visit, 42,33, and 30 patients remained in ... 11:65http://www.biomedcentral.com/1471-244X/11/65Page 3 of 10 neurobiological factors of ADHD, especially in the dopa-minergic system [43]. The mechanism of MPH whichinhibitsthereuptakeofdopamineincreasessynapticdopamine and dopaminergic ... neu-ropsychological measures in hyperactive and non-hyper-active patients [16]. Gorman et al. demonstrated thatMPH ameliorated task-incompatible behavior and atten-tion comparably in both ADHD...
... searches and the databaseanalysis [49] are summarized in Table 3. A number of further pharmaceutical preparations and var-iants of methylphenidate are in phase III of clinical devel-opment in Europe, ... conservative assumptions (cf. Tables 4and 5) regarding diagnosis and treatment prevalencerates, absence of any further increase intreatment inten-sity, a disappointing clinical profile and subsequent ... individual pediatricians and specialists in child andadolescent psychiatry participating in care for patientswith ADHD in Germany. Details on data sources andassumptions are provided in Table...
... separated when she was 4 years old, and a shared contact arrangement with both parents was agreed. After the separation of her parents, patient 4’s behaviour became increasingly challenging. ... courses in managing the child’s behaviour and psychoeducational materials are made available. When pharmacological therapy is recommended, the various types of medication available and their ... following a normal pregnancy and delivery, and had a history of delay in all areas of her development; she walked late, talked late (age 3) and found mainstream schooling very challenging. follow-up...
... who was divorced or separated. Academic perform-ance was assessed by overall grade point average and lastgrade earned in both mathematics and English classesgiven that these two areas are accepted ... FLast grade in English Class (as appears on last report card): A+ A A- B+ B B- C+ C C- D+ D D- FOverall average grade (as appears on last report card):How often do you exercise in an average ... CentralPage 1 of 10(page number not for citation purposes)Annals of General PsychiatryOpen AccessPrimary research A cross-sectional analysis of video games and attentiondeficit hyperactivity...
... 11794-8790, USA, 2Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA and 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46268, ... clini-cal trial design. Ina study optimizing the treatment of ADHD in 25 adults, the combination of atomoxetine andmethylphenidate resulted in small statistically significantmean increases ... analysis of covariance(ANCOVA) comparing changes on the ADHDRS-IV-Par-ent:Inv total score from initial baseline, at the end of studyphase 1, and the end of study phase2. The initial baselinescore...
... Improvement in compliance mayreflect increasing capacity to establish a routine of patchadministration with time, although noncompliance isoften underestimated in any clinical trial.Improvements ... LL, Halperin JM, Abikoff H: Stimulant medications. J AmAcad Child Adolesc Psychiatry 1999, 38:503-512.18. A 14-month randomized clinical trial oftreatment strategiesfor attention- deficit/ hyperactivity ... requiredto have a total score of ≤ 1.5 standard deviations (SDs)from age-appropriate norms on the ADHD-Rating Scale-IV (ADHD-RS-IV) [27], normal laboratory parameters,vital signs, electrocardiogram...
... 76508, USAEmail: James W Varni* - jvarni@archmail.tamu.edu; Tasha M Burwinkle - tburwinkle@swmail.sw.org* Corresponding author AbstractBackground: Attention- Deficit/ HyperactivityDisorder (ADHD) ... Hispanic/Latino, 7 (9.7%) Black/Afri-can American, 7 (9.7%) Asian/Pacific Islander, 2(2.8%)Native American or Native Alaskan, and 9 (12.5%) miss-ing. The statewide SCHIP sample was representative ... PedsQL™4.0. In order to assure the anonymity and confidentiality of the respondent's answers and the neutrality of theorganization gathering the data, all surveys were mailedback to DataStat. Since...
... Nicotinewithdrawal and craving were assessed with a daily diarywhich contained the Minnesota Nicotine WithdrawalScale (MNWS) and self-reported tobacco use [13]. Dailynicotine withdrawal data were obtained ... equations (GEE).Since the target quit-date was the 15thday following thestart of medica tion, separate analyses w ere performedusing data from days 1-14 and 15-28. In all cases, theexplanatory ... concentrations of dopamine in the rewardcenters of the brain [1]. Methylphenidate was consideredas a potential treatment for smokers because of itsaction to block the re-uptake of dopamine by binding...